Abstract
Intratracheal delivery of aerosolized monoclonal antibodies with specificity for Yersinia pestis LcrV and F1 antigens protected mice in a model of pneumonic plague. These data support the utility of inhaled antibodies as a fast-acting postexposure treatment for plague.
Original language | English (US) |
---|---|
Pages (from-to) | 3068-3070 |
Number of pages | 3 |
Journal | Infection and Immunity |
Volume | 74 |
Issue number | 5 |
DOIs | |
State | Published - May 2006 |
ASJC Scopus subject areas
- Parasitology
- Microbiology
- Immunology
- Infectious Diseases